Baillie Gifford & Co
ABMD

Baillie Gifford & Co’s Abiomed Inc ABMD Stock Holding History

Baillie Gifford & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,991
Closed -$1.14M – 490
2022
Q4 		$1.14M Sell
2,991
-3,621,946
-100% -$1.21B ﹤0.01% 270
2022
Q3 		$891M Sell
3,624,937
-84,884
-2% -$22.9M 0.92% 31
2022
Q2 		$918M Buy
3,709,821
+571
+0% +$154K 0.94% 30
2022
Q1 		$1.23B Sell
3,709,250
-130,730
-3% -$40.2M 0.86% 28
2021
Q4 		$1.38B Buy
3,839,980
+106,270
+3% +$35.9M 0.76% 34
2021
Q3 		$1.22B Buy
3,733,710
+100,298
+3% +$34M 0.64% 40
2021
Q2 		$1.13B Buy
3,633,412
+191,084
+6% +$58.6M 0.55% 46
2021
Q1 		$1.1B Buy
3,442,328
+400,501
+13% +$128M 0.61% 43
2020
Q4 		$986M Buy
3,041,827
+96,574
+3% +$26.7M 0.55% 46
2020
Q3 		$816M Buy
2,945,253
+100,149
+4% +$28.9M 0.56% 42
2020
Q2 		$687M Buy
2,845,104
+118,724
+4% +$23.8M 0.52% 41
2020
Q1 		$396M Buy
2,726,380
+6,499
+0.2% +$1.08M 0.43% 51
2019
Q4 		$464M Buy
2,719,881
+27,260
+1% +$5.05M 0.45% 55
2019
Q3 		$479M Buy
2,692,621
+473,485
+21% +$102M 0.54% 47
2019
Q2 		$578M Buy
2,219,136
+1,137,705
+105% +$302M 0.61% 37
2019
Q1 		$309M Buy
1,081,431
+12,572
+1% +$4.18M 0.34% 69
2018
Q4 		$347M Buy
1,068,859
+264,252
+33% +$91.8M 0.45% 59
2018
Q3 		$362M Sell
804,607
-1,301,713
-62% -$513M 0.39% 59
2018
Q2 		$862M Buy
2,106,320
+61,385
+3% +$22.2M 0.93% 24
2018
Q1 		$595M Buy
2,044,935
+95,241
+5% +$24.1M 0.7% 32
2017
Q4 		$365M Sell
1,949,694
-27,267
-1% -$5.09M 0.45% 51
2017
Q3 		$333M Buy
1,976,961
+5,271
+0.3% +$797K 0.42% 55
2017
Q2 		$283M Buy
1,971,690
+299,255
+18% +$40.2M 0.38% 58
2017
Q1 		$209M Buy
1,672,435
+1,084,264
+184% +$126M 0.3% 67
2016
Q4 		$66.3M Buy
588,171
+12,928
+2% +$1.5M 0.11% 88
2016
Q3 		$74M Sell
575,243
-23,110
-4% -$2.77M 0.12% 83
2016
Q2 		$65.4M Sell
598,353
-89,686
-13% -$8.92M 0.12% 86
2016
Q1 		$65.2M Buy
688,039
+400,627
+139% +$33.8M 0.11% 89
2015
Q4 		$25.9M Buy
+287,412
New +$24.4M 0.05% 101

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Baillie Gifford & Co's ABMD Position: Q1 2023 in Review

Baillie Gifford & Co sold out of Abiomed Inc (ABMD) in Q1 2023, closing a stake of 2,991 shares — an estimated $1.14M sold.

Baillie Gifford & Co first reported a position in ABMD in Q4 2015 and held it in 29 quarters. The position peaked at $1.38B in Q4 2021. 2 funds tracked by Wall St. Rank hold ABMD as of Q1 2023.

  • Baillie Gifford & Co reported no remaining Abiomed Inc position as of Q1 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 2,991 Abiomed Inc shares in Q1 2023, an estimated $1.14M.
  • Baillie Gifford & Co first reported a position in Abiomed Inc in Q4 2015 and held it in 29 quarters.
  • Baillie Gifford & Co's Abiomed Inc position peaked at $1.38B in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2023.

Based on Baillie Gifford & Co's 13F filing for Q1 2023, filed 3 May 2023.